
Influenza Virus
Influenza virus inhibitors are compounds that interfere with the replication and spread of influenza viruses. These inhibitors are vital in researching antiviral strategies, understanding the life cycle of the influenza virus, and developing effective treatments and vaccines. Influenza inhibitors can target various stages of the viral replication process, including viral entry, replication, and release. At CymitQuimica, we offer a diverse range of high-quality influenza virus inhibitors to support your research in virology, infectious diseases, and antiviral drug development.
Found 296 products of "Influenza Virus"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Z-VRPR-FMK TFA
<p>Z-VRPR-FMK (TFA), a tetrapeptide, irreversibly inhibits MALT1, protecting against influenza A.</p>Formula:C33H50F4N10O8Color and Shape:SolidMolecular weight:790.81Neuraminidase-IN-16
<p>Neuraminidase-IN-16 (43b) inhibits H5N1, H5N8, H1N1, H3N2, H5N1-H274Y, H1N1-H274Y neuraminidases; IC50: 0.031-10.08 μM.</p>Formula:C26H35FN2O4Color and Shape:SolidMolecular weight:458.57Neuraminidase-IN-22
<p>Neuraminidase-IN-22 (compound 3e) serves as a potent, selective, and orally active inhibitor of neuraminidase, exhibiting a low IC 50 value of 0.03 µM. This compound demonstrates cytotoxic effects and possesses activity against the influenza A virus.</p>Formula:C17H13FN2O2Color and Shape:SolidMolecular weight:296.3Influenza A NP(366-374) Strain A/PR/8/35
CAS:<p>This peptide is an H2-Db-restricted epitope from the Influenza A/PR/8/34 nucleoprotein.</p>Formula:C38H63N11O18S2Purity:98%Color and Shape:SolidMolecular weight:1026.1CEF1, Influenza Matrix Protein M1 (58-66)
CAS:<p>CEF1, M1 (58-66) epitope from influenza A; GILGFVFTL is HLA-A2-restricted.</p>Formula:C49H75N9O11Purity:98%Color and Shape:SolidMolecular weight:966.17PA (224-233), Influenza
CAS:<p>PA (224-233), Influenza is a 10-aa peptide, which is a fragment of polymerase 2 protein in Influenza a virus.</p>Formula:C53H80N14O17Purity:98%Color and Shape:SolidMolecular weight:1185.29Influenza NP (147-155)
CAS:<p>This peptide is a H-2Kd-restricted epitope from Influenza nucleoprotein (147-155).</p>Formula:C48H82N16O14Purity:98%Color and Shape:SolidMolecular weight:1107.26Neuraminidase-IN-12
CAS:<p>NDV-IN-1 is an antiviral inhibiting neuraminidase and the Newcastle disease virus, preventing virion release from Vero cells.</p>Formula:C11H13F3N4O7Color and Shape:SolidMolecular weight:370.24Anti-IAV agent 1
<p>Anti-IAV agent 1 -1a: Orally active, fights influenza A. IC50: 0.03μM for H1N1, 0.06μM for resistant strains.</p>Formula:C28H28FN9O3Color and Shape:SolidMolecular weight:557.58PROTAC Hemagglutinin Degrader-1
<p>PROTAC Hemagglutinin Degrader-1 (V3) degrades influenza HA potently (DC50 1.44 μM) with broad-spectrum antiviral effects.</p>Formula:C61H93N5O9SColor and Shape:SolidMolecular weight:1072.48A-315675
CAS:<p>A-315675 is a neuramidase inhibitor with anti-infuenza activity.</p>Formula:C17H30N2O4Color and Shape:SolidMolecular weight:326.431-Deoxymannojirimycin hydrochloride
CAS:<p>1-Deoxymannojirimycin hydrochloride is a selective α1,2-mannosidase inhibitor(IC50: 20 μM).</p>Formula:C6H14ClNO4Purity:98%Color and Shape:SolidMolecular weight:199.63RdRP-IN-8
<p>RdRP-IN-8 (compound 45) is an antiviral agent targeting influenza viruses. It inhibits the viral RNA-dependent RNA polymerase (RdRP) activity by disrupting the heterodimerization of the PA and PB1 subunits, with an IC50 value of 0.13 μM.</p>Formula:C23H21N3O6SColor and Shape:SolidMolecular weight:467.49Dihydromaniwamycin E
<p>Dihydromaniwamycin E is a heat-shock metabolite exhibiting antiviral activity against influenza and SARS-CoV-2 viruses [1].</p>Formula:C10H22N2O2Color and Shape:SolidMolecular weight:202.29Influenza HA (307-319)
CAS:<p>Influenza Hemagglutinin is an HLA-DRB 0101-restricted epitope from influenza hemagglutinin (307-319).</p>Formula:C69H118N18O19Purity:98%Color and Shape:SolidMolecular weight:1503.78VIR-7229
<p>VIR-7229 is a human IgG1 monoclonal antibody that targets the Receptor-Binding Domain (RBD) of the Spike glycoprotein. It exhibits antiviral activity by competing with ACE2 for binding and inducing the shedding of the S1 protein. VIR-7229 is applicable for research on SARS-CoV-2 infections. Recommended isotype control: Human IgG1 kappa, Isotype Control.</p>Color and Shape:Odour LiquidCletoquine hydrochloride
CAS:<p>Cletoquine hydrochloride, a Hydroxychloroquine metabolite, is a Chloroquine derivative with antimalarial properties and combatting CHIKV.</p>Formula:C16H23Cl2N3OPurity:99.98%Color and Shape:SoildMolecular weight:344.28BCX-1898
CAS:<p>BCX-1898: Oral cyclopentane-based neuraminidase inhibitor for flu A/B; EC50 <0.01-21µM; effective in mouse models.</p>Formula:C17H32N4O3Color and Shape:SolidMolecular weight:340.46HAA-09
CAS:<p>HAA-09: oral anti-influenza with EC50 of 0.03μM; inhibits PB2, IC50 0.06μM; non-toxic, blocks virus replication.</p>Formula:C17H18F2N6O2Color and Shape:SolidMolecular weight:376.36Influenza A virus-IN-1
CAS:<p>Influenza A virus-IN-1, a dihydropyrrolidone, blocks IAV subtypes (IC50: 3.11-7.13 μM), boosts IFN-β and MxA antivirals.</p>Formula:C27H20F6N2O3Color and Shape:SolidMolecular weight:534.458

